On Friday, Sept. 26,
For most people, the reason wouldn’t become clear until a few days later, when the biotech firm
The hedge fund executives behind the deal had spent months searching for a takeover target, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.